Adaptimmune Therapeutics plc (NASDAQ:ADAP) Q1 2021 Earnings Conference Call May 6, 2021 9:00 AM ET Company Participants Juli Miller - Senior Director, IR Adrian Rawcliffe - CEO Elliot Norry - Senior VP and Chief Medical Officer Helen Tayton-Martin - Co-Founder and Chief Business Officer Karen Miller - SVP, Pipeline Research John Lunger - Chief Patient Supply Officer Conference Call Participants Marc Frahm - Cowen and Company Nick Abbott - Wells Fargo Tony Butler - Roth Capital Jonathan Chang - SVB Leerink M ...